questionText: To ask the Secretary of State for Health and Social Care, whether the commitment to explore novel procurement routes for diagnostics or treatments for rarer cancers contained in the 2026 National Cancer Plan includes assessing the suitability of the current approach to marketing authorisation in respect of treatments for rare and less common cancer.
answerText: Improving survival for rare cancer patients is a priority for the National Cancer Plan. The plan aims for England to climb into the top quartile in Europe for survival of multiple less common cancers by 2035.We will explore which innovative procurement me...
heading: Rare Cancers: Health Services